-
Je něco špatně v tomto záznamu ?
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
F. Marchesi, J. Salmanton-García, Z. Emarah, K. Piukovics, M. Nucci, A. López-García, Z. Ráčil, F. Farina, M. Popova, S. Zompi, E. Audisio, MP. Ledoux, L. Verga, B. Weinbergerová, T. Szotkovski, MG. Da Silva, N. Fracchiolla, N. De Jonge, G....
Jazyk angličtina Země Itálie
Typ dokumentu multicentrická studie, časopisecké články, práce podpořená grantem
Grantová podpora
K23 NS110470
NINDS NIH HHS - United States
NLK
Directory of Open Access Journals
od 1994
Free Medical Journals
od 1994
Freely Accessible Science Journals
od 1994
PubMed Central
od 2009
Europe PubMed Central
od 2009
Open Access Digital Library
od 1994-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1996
- MeSH
- akutní myeloidní leukemie * terapie farmakoterapie MeSH
- COVID-19 * MeSH
- dospělí MeSH
- hematologie * MeSH
- lidé MeSH
- následné studie MeSH
- testování na COVID-19 MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients diagnosed with COVID-19 between February 2020 and October 2021. The vast majority were receiving or had received AML treatment in the preceding 3 months. COVID-19 was severe in 41.2% and critical in 21.1% of cases. The chemotherapeutic schedule was modified in 174 patients (44.8%), delayed in 68 and permanently discontinued in 106. After a median follow-up of 325 days, 180 patients (46.4%) had died; death was attributed to COVID-19 (43.3%), AML (26.1%) or to a combination of both (26.7%), whereas in 3.9% of cases the reason was unknown. Active disease, older age, and treatment discontinuation were associated with death, whereas AML treatment delay was protective. Seventy-nine patients had a simultaneous AML and COVID-19 diagnosis, with better survival when AML treatment could be delayed (80%; P<0.001). Overall survival in patients with a diagnosis of COVID-19 between January 2020 and August 2020 was significantly lower than that in patients diagnosed between September 2020 and February 2021 and between March 2021 and September 2021 (39.8% vs. 60% vs. 61.9%, respectively; P=0.006). COVID-19 in AML patients was associated with a high mortality rate and modifications of therapeutic algorithms. The best approach to improve survival was to delay AML treatment, whenever possible.
Aga Khan University Hospital Karachi
Amsterdam UMC location VUmc Amsterdam
AOUP Azienda Ospedaliera Università Pisana Cisanello Pisa
ASST Grande Ospedale Metropolitano Niguarda Milan
Azerbaijan Scientific Research Hematology and Transfusilogy Institute Baku
Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo Alessandria
Azienda Ospedaliera San Gerardo Monza Monza Italy Università Milano Bicocca Milan
Centro Hospitalar e Universitário São João Porto
Complejo Hospitalario de Navarra Iruña Pamplona
Department of Clinical Haematology Yangon General Hospital University of Medicine Yangon
Department of Hematological Medicine Kings College Hospital NHS Foundation Trust London
Department of Hematology and Oncology Medical University of Innsbruck Innsbruck
Department of Hematology Copenhagen University Hospital Rigshospitalet Copenhagen
Department of Infectious Diseases Karolinska University Hospital Stockholm
Department of Internal Medicine Federal University of Rio de Janeiro Rio de Janeiro
Department of Internal Medicine South Division Faculty of Medicine University of Szeged Szeged
Department of Medicine Section of Hematology University of Verona Verona
Department of Nephrology and Infectious diseases AZ Sint Jan Brugge Oostende AV Brugge
Dokuz Eylul University Division of Hematology Izmir
Ematologia con Trapianto Ospedale Dimiccoli Barletta Barletta
Fundacion Jimenez Diaz University Hospital Health Research Institute IIS FJD Madrid
Gomel State Medical University Gomel
Hamad Medical Corporation Division of Infectious Diseases Doha
Hematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome
Hematology Unit ASST Spedali Civili Brescia
Hematology Unit Department of Biomedicine and Prevention Tor Vergata University of Rome
Hematology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan
Hematology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome
Hospital Escuela de Agudos Dr Ramón Madariaga Posadas
Hospital Universitario 12 de Octubre Madrid
Hospital Universitario Marqués de Valdecilla Santander
Hospital Univesitario Virgen del Rocío Seville
Institute of Hematology and Blood Transfusion Prague Czech Republic
IRCCS Ospedale San Raffaele Milan
King's College Hospital London
La Paz University Hospital Madrid
Medical University of Graz Department for Infectious Diseases Graz
North Western State Medical University named after Iliá Ilich Méchnikov Saint Petersburg
Oncology Center Mansoura University Mansoura
Oxford University Hospitals Oxford
Portuguese Institute of Oncology Lisbon
RM Gorbacheva Research Institute Pavlov University St Petersburg
Stem Cell Transplant Center AOU Citta' della Salute e della Scienza Turin
Sultan Qaboos University Hospital Muscat
University Hospital Brno Department of Internal Medicine Hematology and Oncology Brno Czech Republic
University Hospital Dubrava Zagreb Croatia
University Hospital Hradec Králové Hradec Králové Czech Republic
University Hospital Olomouc Olomouc Czech Republic
University Hospital Pilsen Pilsen Czech Republic
University Medical Center Groningen Groningen
University of Kansas Medical Center Kansas City
University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori Milan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004839
- 003
- CZ-PrNML
- 005
- 20240418101112.0
- 007
- ta
- 008
- 230418s2023 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3324/haematol.2022.280847 $2 doi
- 035 __
- $a (PubMed)35545919
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Marchesi, Francesco $u Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome
- 245 10
- $a COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) / $c F. Marchesi, J. Salmanton-García, Z. Emarah, K. Piukovics, M. Nucci, A. López-García, Z. Ráčil, F. Farina, M. Popova, S. Zompi, E. Audisio, MP. Ledoux, L. Verga, B. Weinbergerová, T. Szotkovski, MG. Da Silva, N. Fracchiolla, N. De Jonge, G. Collins, M. Marchetti, G. Magliano, C. García-Vidal, MM. Biernat, J. Van Doesum, M. Machado, F. Demirkan, M. Al-Khabori, P. Žák, B. Víšek, I. Stoma, GA. Méndez, J. Maertens, N. Khanna, I. Espigado, G. Dragonetti, L. Fianchi, MI. Del Principe, A. Cabirta, I. Ormazabal-Vélez, O. Jaksic, C. Buquicchio, V. Bonuomo, J. Batinić, AS. Omrani, S. Lamure, O. Finizio, N. Fernández, I. Falces-Romero, O. Blennow, R. Bergantim, N. Ali, S. Win, J. Van Praet, MC. Tisi, A. Shirinova, M. Schönlein, J. Prattes, M. Piedimonte, V. Petzer, M. Navrátil, A. Kulasekararaj, P. Jindra, J. Sramek, A. Glenthøj, R. Fazzi, C. De Ramón-Sánchez, C. Cattaneo, M. Calbacho, NC. Bahr, S. El-Ashwah, R. Cordoba, M. Hanakova, G. Zambrotta, M. Sciumè, S. Booth, RN. Rodrigues, MV. Sacchi, N. García-Poutón, JA. Martín-González, S. Khostelidi, S. Gräfe, L. Rahimli, E. Ammatuna, A. Busca, P. Corradini, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, OA. Cornely, L. Pagano, EPICOVIDEHA working group
- 520 9_
- $a Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients diagnosed with COVID-19 between February 2020 and October 2021. The vast majority were receiving or had received AML treatment in the preceding 3 months. COVID-19 was severe in 41.2% and critical in 21.1% of cases. The chemotherapeutic schedule was modified in 174 patients (44.8%), delayed in 68 and permanently discontinued in 106. After a median follow-up of 325 days, 180 patients (46.4%) had died; death was attributed to COVID-19 (43.3%), AML (26.1%) or to a combination of both (26.7%), whereas in 3.9% of cases the reason was unknown. Active disease, older age, and treatment discontinuation were associated with death, whereas AML treatment delay was protective. Seventy-nine patients had a simultaneous AML and COVID-19 diagnosis, with better survival when AML treatment could be delayed (80%; P<0.001). Overall survival in patients with a diagnosis of COVID-19 between January 2020 and August 2020 was significantly lower than that in patients diagnosed between September 2020 and February 2021 and between March 2021 and September 2021 (39.8% vs. 60% vs. 61.9%, respectively; P=0.006). COVID-19 in AML patients was associated with a high mortality rate and modifications of therapeutic algorithms. The best approach to improve survival was to delay AML treatment, whenever possible.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a testování na COVID-19 $7 D000086742
- 650 12
- $a COVID-19 $7 D000086382
- 650 12
- $a akutní myeloidní leukemie $x terapie $x farmakoterapie $7 D015470
- 650 12
- $a hematologie $7 D006405
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Salmanton-García, Jon $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne. jon.salmanton-garcia@uk-koeln.de
- 700 1_
- $a Emarah, Ziad $u Oncology Center, Mansoura University, Mansoura
- 700 1_
- $a Piukovics, Klára $u Department of Internal Medicine, South Division Faculty of Medicine University of Szeged, Szeged
- 700 1_
- $a Nucci, Marcio $u Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro
- 700 1_
- $a López-García, Alberto $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid
- 700 1_
- $a Ráčil, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; IRCCS Ospedale San Raffaele, Milan
- 700 1_
- $a Farina, Francesca $u IRCCS Ospedale San Raffaele, Milan
- 700 1_
- $a Popova, Marina $u RM Gorbacheva Research Institute, Pavlov University, St. Petersburg
- 700 1_
- $a Zompi, Sofia $u Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin
- 700 1_
- $a Audisio, Ernesta $u Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin
- 700 1_
- $a Ledoux, Marie-Pierre $u ICANS, Strasbourg
- 700 1_
- $a Verga, Luisa $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy Università Milano-Bicocca, Milan
- 700 1_
- $a Weinbergerová, Barbora $u University Hospital Brno - Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic
- 700 1_
- $a Szotkovski, Tomas $u University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Da Silva, Maria Gomes $u Portuguese Institute of Oncology, Lisbon
- 700 1_
- $a Fracchiolla, Nicola $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
- 700 1_
- $a De Jonge, Nick $u Amsterdam UMC, location VUmc, Amsterdam
- 700 1_
- $a Collins, Graham $u Oxford University Hospitals, Oxford
- 700 1_
- $a Marchetti, Monia $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria
- 700 1_
- $a Magliano, Gabriele $u ASST Grande Ospedale Metropolitano Niguarda, Milan
- 700 1_
- $a García-Vidal, Carolina $u Department of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona
- 700 1_
- $a Biernat, Monika M $u Department of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw
- 700 1_
- $a Van Doesum, Jaap $u University Medical Center Groningen, Groningen
- 700 1_
- $a Machado, Marina $u Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid
- 700 1_
- $a Demirkan, Fatih, $d 1965- $u Dokuz Eylul University, Division of Hematology, Izmir $7 xx0316387
- 700 1_
- $a Al-Khabori, Murtadha $u Sultan Qaboos University Hospital, Muscat
- 700 1_
- $a Žák, Pavel $u University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Víšek, Benjamín $u University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Stoma, Igor $u Gomel State Medical University, Gomel
- 700 1_
- $a Méndez, Gustavo-Adolfo $u Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas
- 700 1_
- $a Maertens, Johan $u Department of Microbiology, Immunology, and Transplantation, KULeuven, Leuven and Department of Hematology, UZ Leuven, Leuven
- 700 1_
- $a Khanna, Nina $u Division of Infectious Diseases and Hospital Epidemiology, and Department of Clinical Research, University and University Hospital of Basel, Basel
- 700 1_
- $a Espigado, Ildefonso $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CSIC), Universidad de Sevilla (Departamento de Medicina), Seville
- 700 1_
- $a Dragonetti, Giulia $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome
- 700 1_
- $a Fianchi, Luana $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome
- 700 1_
- $a Del Principe, Maria Ilaria $u Hematology Unit, Department of Biomedicine and Prevention, Tor Vergata University of Rome
- 700 1_
- $a Cabirta, Alba $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra
- 700 1_
- $a Ormazabal-Vélez, Irati $u Complejo Hospitalario de Navarra, Iruña-Pamplona
- 700 1_
- $a Jaksic, Ozren $u University Hospital Dubrava, Zagreb, Croatia
- 700 1_
- $a Buquicchio, Caterina $u Ematologia con Trapianto, Ospedale Dimiccoli Barletta, Barletta
- 700 1_
- $a Bonuomo, Valentina $u Department of Medicine, Section of Hematology, University of Verona, Verona
- 700 1_
- $a Batinić, Josip $u University Hospital Centre Zagreb, Zagreb, Croatia Croatian Cooperative Group for Hematological Diseases (CROHEM), Croatia Faculty of Medicine University of Zagreb, Zagreb, Croatia
- 700 1_
- $a Omrani, Ali S $u Hamad Medical Corporation, Division of Infectious Diseases, Doha
- 700 1_
- $a Lamure, Sylvain $u Département d'Hématologie Clinique, CHU de Montpellier, UMR-CNRS 5535, Universite de Montpellier, Montpellier
- 700 1_
- $a Finizio, Olimpia $u UOC Hematology, AORN Cardarelli, Naples
- 700 1_
- $a Fernández, Noemí $u Hospital Universitario Marqués de Valdecilla, Santander
- 700 1_
- $a Falces-Romero, Iker $u La Paz University Hospital, Madrid
- 700 1_
- $a Blennow, Ola $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm
- 700 1_
- $a Bergantim, Rui $u Centro Hospitalar e Universitário São João, Porto
- 700 1_
- $a Ali, Natasha $u Aga Khan University Hospital, Karachi
- 700 1_
- $a Win, Sein $u Department of Clinical Haematology, Yangon General Hospital, University of Medicine, Yangon
- 700 1_
- $a Van Praet, Jens $u Department of Nephrology and Infectious diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge
- 700 1_
- $a Tisi, Maria Chiara $u Ospedale San Bortolo, Vicenza
- 700 1_
- $a Shirinova, Ayten $u Azerbaijan Scientific Research Hematology and Transfusilogy Institute, Baku
- 700 1_
- $a Schönlein, Martin $u Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg
- 700 1_
- $a Prattes, Juergen $u Medical University of Graz, Department for Infectious Diseases, Graz
- 700 1_
- $a Piedimonte, Monica $u AOU Sant'Andrea, Rome
- 700 1_
- $a Petzer, Verena $u Department of Hematology and Oncology, Medical University of Innsbruck, Innsbruck
- 700 1_
- $a Navrátil, Milan $u Head of the ICU and Transplant Unit, Department of Hematooncology, University Hospital of Ostrava, Ostrava-Poruba, Czech Republic
- 700 1_
- $a Kulasekararaj, Austin $u King's College Hospital, London
- 700 1_
- $a Jindra, Pavel $u University Hospital Pilsen, Pilsen, Czech Republic
- 700 1_
- $a Sramek, Jiří $u Department of Hematology and Oncology, University Hospital Pilsen, Czech Republic Department of Histology and Embryology, Faculty of Medicine, Pilsen, Czech Republic
- 700 1_
- $a Glenthøj, Andreas $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen
- 700 1_
- $a Fazzi, Rita $u AOUP - Azienda Ospedaliera Università Pisana - Cisanello, Pisa
- 700 1_
- $a De Ramón-Sánchez, Cristina $u Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain IBSAL, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca
- 700 1_
- $a Cattaneo, Chiara $u Hematology Unit, ASST-Spedali Civili, Brescia
- 700 1_
- $a Calbacho, Maria $u Hospital Universitario 12 de Octubre, Madrid
- 700 1_
- $a Bahr, Nathan C $u University of Kansas Medical Center, Kansas City
- 700 1_
- $a El-Ashwah, Shaimaa $u Oncology Center, Mansoura University, Mansoura
- 700 1_
- $a Cordoba, Raul $u Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid
- 700 1_
- $a Hanakova, Michaela $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Zambrotta, Giovanni $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy Università Milano-Bicocca, Milan
- 700 1_
- $a Sciumè, Mariarita $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
- 700 1_
- $a Booth, Stephen $u Oxford University Hospitals, Oxford
- 700 1_
- $a Rodrigues, Raquel Nunes $u Portuguese Institute of Oncology, Lisbon
- 700 1_
- $a Sacchi, Maria Vittoria $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria
- 700 1_
- $a García-Poutón, Nicole $u Department of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona
- 700 1_
- $a Martín-González, Juan-Alberto $u Hospital Univesitario Virgen del Rocío, Seville
- 700 1_
- $a Khostelidi, Sofya $u North-Western State Medical University named after Iliá Ilich Méchnikov, Saint-Petersburg
- 700 1_
- $a Gräfe, Stefanie $u Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne
- 700 1_
- $a Rahimli, Laman $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne
- 700 1_
- $a Ammatuna, Emanuele $u University Medical Center Groningen, Groningen
- 700 1_
- $a Busca, Alessandro $u Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin
- 700 1_
- $a Corradini, Paolo $u University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
- 700 1_
- $a Hoenigl, Martin $u Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA, United States Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, CA, United States Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz
- 700 1_
- $a Klimko, Nikolai $u North-Western State Medical University named after Iliá Ilich Méchnikov, Saint-Petersburg
- 700 1_
- $a Koehler, Philipp $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne
- 700 1_
- $a Pagliuca, Antonio $u Department of Hematological Medicine, Kings College Hospital NHS Foundation Trust, London
- 700 1_
- $a Passamonti, Francesco $u Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese
- 700 1_
- $a Cornely, Oliver A $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Cologne, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging- Associated Diseases (CECAD), Cologne, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne
- 700 1_
- $a Pagano, Livio $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy Hematology Unit, Università Cattolica del Sacro Cuore, Rome
- 710 2_
- $a EPICOVIDEHA working group
- 773 0_
- $w MED00001963 $t Haematologica $x 1592-8721 $g Roč. 108, č. 1 (2023), s. 22-33
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35545919 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20240418101106 $b ABA008
- 999 __
- $a ok $b bmc $g 1925121 $s 1191048
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 108 $c 1 $d 22-33 $e 20230101 $i 1592-8721 $m Haematologica $n Haematologica $x MED00001963
- GRA __
- $a K23 NS110470 $p NINDS NIH HHS $2 United States
- LZP __
- $a Pubmed-20230418
